Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

[1]  D. Hayes,et al.  Circulating tumour cells: insights into tumour heterogeneity , 2013, Journal of internal medicine.

[2]  K. Pantel,et al.  Current status in human breast cancer micrometastasis , 2007, Current opinion in oncology.

[3]  Soonmyung Paik,et al.  Use of archived specimens in evaluation of prognostic and predictive biomarkers. , 2009, Journal of the National Cancer Institute.

[4]  K. Dardoufas,et al.  Cell‐free DNA and RNA in Plasma as a New Molecular Marker for Prostate and Breast Cancer , 2006, Annals of the New York Academy of Sciences.

[5]  Carlos Caldas,et al.  Analysis of circulating tumor DNA to monitor metastatic breast cancer. , 2013, The New England journal of medicine.

[6]  S. Teutsch,et al.  The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group , 2009, Genetics in Medicine.

[7]  Helen M. Moore,et al.  Biospecimen reporting for improved study quality (BRISQ). , 2012, Clinica chimica acta; international journal of clinical chemistry.

[8]  R. Bast,et al.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.